Skip to main content

Table 1 The demographic and clinical data of the patients with RB and healthy controls

From: Quantitative evaluation of retinal microvasculature and retrobulbar vessels after intravenous chemotherapy for retinoblastoma

Ā 

Group I

Group II

Control

P value

Number of subjects

10

10

10

Ā 

Age (years)

9.7ā€‰Ā±ā€‰2.4

8.8ā€‰Ā±ā€‰2.3

9.6ā€‰Ā±ā€‰1.7

Ā 

Gender, n

ā€ƒMale

5

4

6

Ā 

ā€ƒFemale

5

6

4

Ā 

Tumor consolidation, n

ā€ƒCryotherapy

8

0

0

Ā 

ā€ƒTTT

9

0

0

Ā 

ā€ƒCryotherapy + TTT

7

0

0

Ā 

BCVA (logMAR)

0

0

0

Ā 

Axial Length (mm)

23.0ā€‰Ā±ā€‰1.1

22.9ā€‰Ā±ā€‰0.8

23.1ā€‰Ā±ā€‰0.7

Ā 

First presentation time (mouth) (mouth)

12.9ā€‰Ā±ā€‰7.7

30.1ā€‰Ā±ā€‰9.6

Ā 

0.0003

Duration time (year)

8.2ā€‰Ā±ā€‰2.4

7.3ā€‰Ā±ā€‰2.4

Ā 

0.4127

IVC times

6.5ā€‰Ā±ā€‰1.6

6.5ā€‰Ā±ā€‰1.6

Ā 

1

Family history, n (%)

1(10%)

0

Ā Ā 
  1. Values are expressed as the meanā€‰Ā±ā€‰SD. pĀ <ā€‰0.05 was considered statistically significant
  2. BCVA Best-corrected visual acuity, logMAR Logarithm of the minimum angle of resolution, IVC Intravenous chemotherapy. Duration time Duration from last IVC to time of the exam